Westminster, CO – Reed Group recently announced the introduction of a groundbreaking drug formulary based on the American College of Occupational and Environment Medicine (ACOEM) Practice Guidelines.
Set to launch as an integrated tool within MDGuidelines in November of 2015, “this innovative drug formulary will be the only formulary within the workers’ compensation arena with therapeutic agent recommendations tied specifically to work-related injuries and illnesses as well as the phase of care, either acute or chronic,” said Senior Vice President of MDGuidelines, Joe Guerriero. “It will be a unique tool to promote quality of care, positive therapeutic outcomes, and safe, cost-effective drug choices.”
“By basing this formulary on ACOEM’s Practice Guidelines, the playing field dramatically changes for health care providers and work force managers across the country. They now have the better choice of a widely used clinical reference that can provide recommendations for the most appropriate medication therapy for their patients as opposed to relying on a basic drug list,” said Kurt Hegmann, M.D., MPH, Editor-in-Chief of the ACOEM Practice Guidelines.
To build this formulary, Reed Group sought a leader in clinically-focused, comprehensive solutions for pharmacy benefit management, Healthesystems, known for their expertise in workers’ compensation drug formulary creation. Dr. Robert Goldberg, M.D., the Chief Medical Officer at Healthesystems, worked in conjunction with pharmacists and Dr. Hegmann.
“This formulary will set the standard and shape the future of treatment for workplace injuries and illnesses,” said Dr. Goldberg. “The ACOEM Practice Guidelines provide an invaluable framework for this formulary’s clinical development and will serve as the foundation to ensure users are guided to the right medication treatment recommendation at the right time. Treatment decisions are far too important to rely on generalized information that is not specific to injury or illness.”
Developed by pharmacists and physicians along with input from external peer reviewers, the formulary will provide inclusions and exclusions in an easy-to-understand and updated format for physicians and other health care professionals, including clinical case managers, insurers and third-party administrators.
ACOEM’s Practice Guidelines are solely available from Reed Group, making the availability of this drug formulary exclusive to MDGuidelines. The launch of this new drug formulary is one of several upcoming major enhancements to the MDGuidelines suite of products and services.
Healthesystems is a WorkCompWire Ad Partner.
This is not a paid placement.